What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Stephen D. Silberstein focuses on Migraine, Anesthesia, Placebo, Randomized controlled trial and Headaches.
His Migraine research integrates issues from Physical therapy, Clinical trial and Pediatrics.
His Physical therapy study deals with International Classification of Headache Disorders intersecting with Cluster headache.
The Anesthesia study combines topics in areas such as Frovatriptan, Central nervous system disease, Neurological disorder and Vagus nerve stimulation.
His Placebo study combines topics from a wide range of disciplines, such as Tolerability, Severity of illness, Subgroup analysis and Clinical endpoint.
His studies examine the connections between Randomized controlled trial and genetics, as well as such issues in Adverse effect, with regards to Surgery.
His most cited work include:
- The International Classification of Headache Disorders, 3rd edition (beta version) (5079 citations)
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial (631 citations)
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program (574 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Migraine, Anesthesia, Chronic Migraine, Internal medicine and Headaches.
He combines subjects such as Tolerability, Adverse effect, Placebo, Physical therapy and Pediatrics with his study of Migraine.
He has researched Pediatrics in several fields, including Aura and Topiramate.
His Anesthesia study incorporates themes from Randomized controlled trial, Neurological disorder and Sumatriptan.
Stephen D. Silberstein integrates Chronic Migraine with In patient in his study.
His research in Nausea intersects with topics in Photophobia and Phonophobia.
He most often published in these fields:
- Migraine (68.18%)
- Anesthesia (35.64%)
- Chronic Migraine (19.64%)
What were the highlights of his more recent work (between 2015-2021)?
- Migraine (68.18%)
- Chronic Migraine (19.64%)
- Internal medicine (17.64%)
In recent papers he was focusing on the following fields of study:
Migraine, Chronic Migraine, Internal medicine, Placebo and Tolerability are his primary areas of study.
The concepts of his Migraine study are interwoven with issues in Clinical trial, Adverse effect, Randomized controlled trial, Intensive care medicine and Calcitonin gene-related peptide.
His Clinical trial research is multidisciplinary, incorporating perspectives in Physical therapy and Pediatrics.
His Chronic Migraine study is related to the wider topic of Anesthesia.
Stephen D. Silberstein studies Cluster headache which is a part of Anesthesia.
Stephen D. Silberstein has included themes like Nausea, Clinical endpoint and Dosing in his Placebo study.
Between 2015 and 2021, his most popular works were:
- Fremanezumab for the Preventive Treatment of Chronic Migraine (279 citations)
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial (276 citations)
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial (194 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Stephen D. Silberstein spends much of his time researching Migraine, Internal medicine, Chronic Migraine, Clinical trial and Placebo.
His study in Migraine is interdisciplinary in nature, drawing from both Tolerability, Randomized controlled trial, Calcitonin gene-related peptide, Dosing and Headaches.
His Chronic Migraine study is concerned with the larger field of Anesthesia.
His work in Anesthesia covers topics such as Vagus nerve stimulation which are related to areas like Cluster headache.
His Clinical trial research includes themes of Gastroenterology, Intensive care medicine, Pathophysiology, Headache Disorders and Physical therapy.
His work deals with themes such as Nausea, Photophobia, Clinical endpoint and Phonophobia, which intersect with Placebo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
